The association between the gene encoding 5-lipoxygenase activating protein and abdominal aortic aneurysms

Atherosclerosis

Volumn 220, Issue 2, 2012, Pages 425-428

  Bisoendial, Radjesh J ^a   Tanck, Michael W ^b   Golledge, Jonathan ^c   Broekhuizen, Lysette N ^a   Legemate, Dink A ^a   Stroes, Erik S G ^a   Norman, Paul E ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c JAMES COOK UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

5 Lipoxygenase activating protein; Aneurysm formation; Inflammation; Leukotrienes

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

5-LIPOXYGENASE-ACTIVATING PROTEINS; AGED; AORTIC ANEURYSM, ABDOMINAL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; NETHERLANDS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 84855971147     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.040     Document Type: Article

References (15)

1. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006, 26(December (12)):2605-2613.
2. Haeggstrom J.Z., Funk C.D. Lipoxygenase and leukotriene pathways: biochemistry. biology, and roles in disease. Chem Rev 2011, 111(October (12)):5866-5898.
3. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36(March (3)):233-239.
4. Helgadottir A., Gretarsdottir S., St C.D., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005, 76(March (3)):505-509.
5. Hakonarson H., Thorvaldsson S., Helgadottir A., et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA 2005, 293(May (18)):2245-2256.
6. Zhao L., Moos M.P., Grabner R., et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 2004, 10(September (9)):966-973.
7. Ahluwalia N., Lin A.Y., Tager A.M., et al. Inhibited aortic aneurysm formation in BLT1-deficient mice. J Immunol 2007, 179(July (1)):691-697.
8. Norman P.E., Flicker L., Almeida O.P., et al. Cohort profile the health in men study (HIMS). Int J Epidemiol 2009, 38(February (1)):48-52.
9. Norman P.E., Jamrozik K., Lawrence-Brown M.M., et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004, 329(November (7477)):1259.
10. Koch W., Hoppmann P., Mueller J.C., Schomig A., Kastrati A. No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population. Genet Med 2007, 9(February (2)):123-129.
11. Girelli D., Martinelli N., Trabetti E., et al. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study. Eur J Hum Genet 2007, 15(September (9)):959-966.
12. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68(April (4)):978-989.
13. Souverein O.W., Zwinderman A.H., Tanck M.W. Estimating haplotype effects on dichotomous outcome for unphased genotype data using a weighted penalized log-likelihood approach. Hum Hered 2006, 61(2):104-110.
14. Maznyczka A., Mangino M., Whittaker A., et al. Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction. Clin Sci (Lond) 2007, 112(June (7)):411-416.
15. Vikman S., Brena R.M., Armstrong P., et al. Functional analysis of 5-lipoxygenase promoter repeat variants. Hum Mol Genet 2009, 18(December (23)):4521-4529.